US Broker Ratings

PGIM Securitized Income ETF (PINC) Stock Analysis: Navigating Stability with a $4.07 Billion Market Cap

In a financial landscape often characterized by volatility and uncertainty, the PGIM Securitized Income ETF (NYSEARCA: PINC) stands out for its steady approach to investing. With..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 34.86% Potential Upside

Progyny, Inc. (PGNY), a prominent player in the healthcare plans sector, is redefining fertility and family-building benefits in the United States. With a market capitalization of..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Giant with Strong Buy Ratings and a 9.6% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a prominent player in the biotechnology industry, has captured investor attention with its robust portfolio and promising growth metrics. With a..

Disc Medicine, Inc. (IRON) Stock Analysis: Potential Upside Sparks Investor Interest Amid Biotech Innovations

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, has drawn significant attention in the investment community with its innovative approach to tackling serious hematologic diseases...

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Unveiling a 64% Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company entrenched in the healthcare sector, is capturing investor attention with its promising developments in the biotechnology industry. Headquartered..

Agios Pharmaceuticals (AGIO): Investor Outlook Reveals a Promising 38% Upside Potential

Agios Pharmaceuticals, Inc. (AGIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust pipeline and promising growth potential. Headquartered..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 22% Upside Potential

Guardian Pharmacy Services, Inc. (GRDN), a notable player in the healthcare sector specializing in medical care facilities, is grabbing investor attention with its promising upside potential..

Immunovant, Inc. (IMVT) Investor Outlook: Analyzing the 45.94% Upside Potential

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company, is capturing investor attention with its promising 45.94% upside potential. Specializing in developing targeted therapies for autoimmune diseases,..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating a 23.2% Revenue Growth in a Challenging Market

Twist Bioscience Corporation (TWST), a prominent player in the biotechnology sector, has captured the attention of investors with its significant revenue growth of 23.2%, despite a..

Concentra Group Holdings (CON): Investor Outlook Reveals 15.95% Upside Potential

For investors eyeing the healthcare sector, Concentra Group Holdings Parent (CON) presents an intriguing opportunity. As a key player in the medical care facilities industry, Concentra..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals 38.45% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company focusing on the development and commercialization of treatments for central nervous system (CNS) diseases, has captured the attention..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Tapping into a 143.64% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a prominent player in the biotechnology sector, is capturing investor attention with its promising portfolio of treatments for rare diseases. With..

Acadia Healthcare (ACHC) Stock Analysis: Navigating Market Headwinds with Potential 21% Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent provider of behavioral healthcare services, finds itself at a pivotal moment. With a market capitalization of $2.6 billion,..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Exploring a Potential 216.49% Upside

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is garnering significant attention from investors due to its promising pipeline of therapies..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eye-Catching Growth with a 29.54% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is catching the attention of investors with its impressive potential upside of 29.54%. As a commercial-stage biopharmaceutical company, Tarsus is focused..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Closer Look at a Potential 29.95% Upside for Investors

For investors keeping an eye on the healthcare sector, LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity. This Burlington, Massachusetts-based company, with a market capitalization..

Surgery Partners, Inc. (SGRY) Stock Analysis: Eyeing a 28.10% Upside with Solid Analyst Ratings

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the U.S. healthcare sector, is catching the attention of investors with its potential for a notable 28.10%..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Navigating High Growth with Strategic Clinical Trials

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a biotechnology company specializing in therapeutics for rare endocrine diseases, is drawing attention in the healthcare sector with its impressive revenue..

Warby Parker Inc. (WRBY) Stock Analysis: A 23.53% Potential Upside Amidst Strong Buy Ratings

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s medical instruments and supplies industry, has carved out a niche in the eyewear market..

ICU Medical, Inc. (ICUI)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds